Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5428]

Phase I/II study shows increased PFS for patients with r/r multiple myeloma who received ixazomib in combination with pomalidomide and dexamethasone

Phase I/II study shows increased PFS for patients with r/r multiple myeloma who received ixazomib in combination...

Novel therapy for recurrent brain tumours

Novel therapy for recurrent brain tumours

Study details chromosome-level changes that allow melanomas to develop drug resistance

Study details chromosome-level changes that allow melanomas to develop drug resistance

Analysis tool leads to more-accurate evaluation of new brain tumour treatments and individual estimates of survival

Analysis tool leads to more-accurate evaluation of new brain tumour treatments and individual estimates of survival

Researchers zero in on therapeutic target for aggressive uterine cancer

Researchers zero in on therapeutic target for aggressive uterine cancer

Lung cancer death decline associated with screening, earlier diagnosis, and surgery

Lung cancer death decline associated with screening, earlier diagnosis, and surgery

Prostate cancer medicine not a cure for COVID-19

Prostate cancer medicine not a cure for COVID-19

Amivantamab, the first treatment approved for patients with advanced NSCLC with EGFR exon 20 insertion mutations after failure of platinum-based therapy

Amivantamab, the first treatment approved for patients with advanced NSCLC with EGFR exon 20 insertion mutations...

Investigator helps chart progress in clinical trial of patients with chemoresistant triple-negative breast cancer

Investigator helps chart progress in clinical trial of patients with chemoresistant triple-negative breast cancer

Repurposed drug shows improved results with combined therapy for triple negative breast cancer

Repurposed drug shows improved results with combined therapy for triple negative breast cancer

More from ecancer